Skip to content

Clinical trials

Schizophrenia trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Puerto Rico Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20043
20051
20063
20082
20092
20103
20114
20132
20162
20171
20181
20191
20212
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated7
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Denovo Biopharma LLC4
AbbVie3
Alkermes, Inc.3
Karuna Therapeutics, Inc., a Bristol Myers Squibb company2
Neurocrine Biosciences2
Sumitomo Pharma America, Inc.2
Janssen Scientific Affairs, LLC1
Woodbury, Michel, M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia32
Psychotic Disorders5
Bipolar Disorder3
Autistic Disorder2
Autism Spectrum Disorder1
Body Weight1
Mania1
Mental Disorders1
Schizophrenia Spectrum and Other Psychotic Disorders1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.